Analysis of conflicts of interest in pharmaceutical payments made to Food and Drug Administration physician advisers after dermatologic drug approval - 09/11/19
Doi : 10.1016/j.jaad.2019.05.059
Stephanie L. Kuschel, BA a, Claudia M. Ricotti, BS b, Cory A. Dunnick, MD c, d, Jeremy Hugh, MD c, d, Robert P. Dellavalle, MD, PhD, MSPH c, d, ⁎ 
a Indiana University School of Medicine, Indianapolis, Indiana
b University of Cincinnati College of Medicine, Cincinnati, Ohio
c Department of Dermatology, University of Colorado School of Medicine, Aurora, Colorado
d Dermatology Service, Rocky Mountain Regional VA Medical Center, Aurora, Colorado
∗Correspondence to: Robert P. Dellavalle MD, PhD, MSPH, Dermatology Service, Rocky Mountain Regional VA Medical Center, 1700 N Wheeling St, Room E1-342, Aurora, CO 80045Dermatology ServiceRocky Mountain Regional VA Medical Center1700 N Wheeling St, Room E1-342AuroraCO80045
Abbreviation used : FDA
| Stephanie L. Kuschel and Claudia M. Ricotti are co-first authors. |
|
| Funding sources: None. |
|
| Conflicts of interest: None disclosed. |
|
| Prior presentation: An abstract and poster presentation on this topic was delivered at the 2019 American Academy of Dermatology Annual Meeting, Washington, DC, March 1-5, 2019. |
|
| Reprint requests are available from Stephanie Kuschel, e-mail: skuschel@iu.edu |
© 2019
Publié par Elsevier Masson SAS.
Vol 81 - N° 6
P. 1419-1420 - décembre 2019 Retour au numéro
Article précédent
- Retrospective cohort study of anatomic localization of cutaneous squamous cell carcinomas in solid organ transplant recipients compared with immunocompetent patients
- Joyce Y. Cheng, Fang-Yong Li, Mike Wang, Oscar R. Colegio
- Parental support for sun-protection policies in schools: A cross-sectional analysis
- Anna Kozlowski, Erin Dodd, Brooke Hanson, DeAnn Lazovich, Ingrid Polcari
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?